Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC6647002/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC6647002/. The analysis below is for the second page.

Title[redir]:
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial - PMC
Description:
This phase 2 randomized clinical trial assesses the safety and efficacy of durvalumab with and without tremelimumab for the treatment of patients with metastatic pancreatic ductal adenocarcinoma.

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 6,732,313 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We can't see how the site brings in money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Ncbi.nlm.nih.gov might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

doi, patients, therapy, google, scholar, pancreatic, pubmed, cancer, pmc, durvalumab, article, combination, free, part, tumor, monotherapy, study, arm, treatment, data, immune, tremelimumab, blockade, cells, adenocarcinoma, efficacy, response, checkpoint, mpdac, expression, randomized, trial, safety, pdl, pdac, ductal, phase, clinical, disease, months, patient, survival, metastatic, weeks, adverse, supplement, oncol, events, rate, cell,

Topics {✒️}

dual anti–pd-1/anti–ctla-4 blockade anti-programmed cell death-ligand-1 designate pd-l1–high expression pd-l1–low/negative expression support pd-l1/ctla-4 blockade anti–pd-1/pd-l1 mabs pd-l1–expressing tumor cells anti–programmed death–ligand 1 focal adhesion kinase human anticytotoxic t-lymphocyte active t-cell suppression pmc beta search phosphor-integrated dot staining paraffin-embedded tumor tissue myeloid-derived suppressor cells recurrent squamous-cell carcinoma small-cell lung cancer t-cell checkpoint immunotherapy pd-1/pd-l1 blockade anti–pd-l1 antibody evaluate pd-l1 expression tab pd-l1 expression anti–ctla-4 mab resulted key points question programmed death-ligand 1 late-stage clinical trials [google scholar] 13 treatment-related adverse events microsatellite instability–high status poor prognostic factor gemcitabine-based chemotherapy regimen primary end point progression-free survival full trial protocol combination immuno-oncology therapy dual checkpoint inhibition concurrent platinum-based chemotherapy t-cell activation anticytotoxic t-lymphocyte license information pmcid unacceptable toxic effects pd-l1–high gov/ftp1/ctcae/ctcae_4 pd-l1–low pd-l1 expression anti–pd-l1 /anti–pd-l1 anti–ctla-4 mabs metastatic pancreatic adenocarcinoma common adverse events

Questions {❓}

  • Does combination immuno-oncology therapy (anti–programmed death–ligand 1 and anticytotoxic T-lymphocyte–associated antigen 4) provide clinical benefit for patients with metastatic pancreatic ductal adenocarcinoma?
  • The stromal compartments in pancreatic cancer: are there any therapeutic targets?

Social Networks {👍}(6)

External Links {🔗}(102)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

3.35s.